Navigation Links
SafeHands' School Program to Help Fight Spread of MRSA Staph Virus
Date:10/25/2007

"Sanitize Your Hands Whenever You Can" Geared to Change Student Behavior

BOCA RATON, Fla., Oct. 25 /PRNewswire/ -- SafeHands(R), Inc. is marketing its proprietary alcohol-free instant hand sanitizer to help prevent the spread of germs including the deadly MRSA (Staph) virus. The virus, known to spread from hand-to-hand contact, has resulted in the death of at least one student and has made hundreds of others seriously ill across the country. The Centers for Disease Control recently declared fatalities from this "Superbug" may even surpass the death toll of AIDS.

SafeHands founder and CEO, Dr. Jay Reubens stated, "We are receiving calls from school officials from across the country expressing concern about the health and safety of their students." SafeHands recently began marketing its alcohol-free product to schools, day care and prisons in response to their ban on alcohol hand sanitizers. SafeHands national launch will take place at the ISSA Show on October 24th at the Orange County Florida Convention Center.

SafeHands products have been subjected to stringent microbiological laboratory and independent human subject testing at California State University, Fresno where it was proven that SafeHands has a more persistent kill rate of germs than alcohol sanitizers without any drying effects on hands.

Dr. Reubens added, "Most people do not realize that alcohol kills germs by stripping away the skin's natural oils. This is why there are so many complaints about skin drying and cracking. The more dry and cracked the hands becomes the more likely germs will be trapped in the skin which leads to a greater potential for cross contamination". Dr. Reubens concluded, "SafeHands is the best alternative because it has a germ killing profile that is comparable to alcohol but more persistent and unlike alcohol it is non-skin drying, non-toxic and non-flammable".

Tom Johnson, National Sales Manager, stated, "SafeHands' 'Sanitize Your Hands Wheneve
'/>"/>

SOURCE SafeHands Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. School Children Put To Risk Due To Shortage Of Nurses
2. Schools and Bars closed in Rwanda due to Cholera outbreak
3. Does Success in School Differ From the Real World Success ?
4. Preschoolers eat more when served in bigger helpings
5. Watching TV in the bedroom can lower children’s school performanc
6. Exposure to Pesticides in Schools Produces Illnesses Among Employees, Students
7. Adolescents Who Walk To School Are Fitter, More Active
8. Safe Neighborhood Means Less TV For Preschool Children
9. Popularity Among Peers Increases Susceptibility To Smoking Habit Among School Children
10. Vitamin filled nutrition candy for School children
11. Fish Oil supplementation reduces physical aggression in school children’
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)...eyed MCO Pharmacy Directors Will Move Razadyne and...zadyne is Launched, According to a New ... Mass., July 9 /PRNewswire/ -- Decision Resources,...firms for pharmaceutical and,healthcare issues, fi.../Ortho McNeil,s Razadyne (galantamine) in December...
(Date:7/9/2008)...ve day OnBase deployment critical in electronic he...t patients, CLEVELAND, July 9 /PRNewswire/ -- Hyl...e document management software suite, announced th...ts since the deployment of,OnBase in March. Based ...ur,states, SSM is a forward-thinking health care p...
(Date:7/9/2008)..., July 9 /PRNewswire-FirstCall/ - MDS Inc. (TSX: M... services to the global life,sciences markets, tod...anada Limited (AECL) with notice of arbitration pr...AECL to fulfill its contractual obligations,under ...LTSA) and if not,granted, seeking significant mone...
(Date:7/9/2008)... DRE, Inc., a premier international ...ts customers that as much as $250,000 in medical e...e tax filings. , Louisvil...us Act of 2008, in accordance with Tax Code Sectio...equipment bought in 2008. This could make 2008 an ...
Breaking Medicine News(10 mins):Health News:Primary Care Physicians' Prescriptions of Aricept for Alzheimer's Disease Will Drop by 20 Percent Following the Availability of Generic Razadyne in December 2008 2Health News:Primary Care Physicians' Prescriptions of Aricept for Alzheimer's Disease Will Drop by 20 Percent Following the Availability of Generic Razadyne in December 2008 3Health News:SSM Health Care Upgrades Patient Care With Speedy Document Management Implementation 2Health News:SSM Health Care Upgrades Patient Care With Speedy Document Management Implementation 3Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 2Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 3Health News:Economic Stimulus Act Can Improve Medical Equipment Purchasing Power 2
...s over the practice of "Breast Ironing" in West A...t and is used to stunt breast growth in girls by m...is for their own good. It is aimed at warding off...by hard or heated objects pressed against the deve...
...atment of breast cancer, researchers have discover...sue when standard chemotherapy is combined with a ...involved in causing cancer. In a multicenter clini...issue of the Journal of Clinical Oncology, women w...
... would exempt the millions of vulnerable Medicaid ... give proof of their citizenship// by showing pass...s move was mainly seen as an attempt to pre-empt a...led to hold a hearing on Friday on a lawsuit chall...
...re six new ways to fight HIV/AIDS in the next five... Malaysia said that the plan, which was approved ...er the 9th Malaysia Plan. “One of the strategies i... leadership, commitment and collaboration in fight...
Other Medicine News:Health News:Significant Advance in Treatment of Breast Cancer Reported 2Health News:Bush Administration to Exempt Medicaid Recipients on Proof of Citizenship 2
(Date:7/7/2008)...lar Biometrics presents scientific evidence suppor...bolomics platform at major international ... and CHESTER, N.J., July 7 /- Molecul...company developing novel,clinical tools for applic...,characterize biologic function in health and dise...
(Date:7/7/2008)... New Study Suggests Kiwifruit is Top Performer in ... fruits are created equal when,it comes to their a...the,highest in bioavailability compared to other a...ll-scale study published in the Journal of the,Ame... vitamins and phytochemicals called flavonoids tha...
(Date:7/3/2008)...BRUNSWICK, N.J., July 3 /- ...any") (Amex: SNT ) announced today,that it has co...I") to,supply the plasmid portion of the Company,s...ene and siRNA against Factor 5A., Senesco has pre...lts,using its combination siRNA and plasmid agains...
(Date:7/1/2008)...sion of Five-Day Dosing Regimen sNDA Targeted for ...008, WOODCLIFF LAKE, N.J., July 1, 2008 /PRNewswi...nounced the preliminary efficacy data from a trial...e) to Best Supportive Care,(BSC) in elderly patien...did not demonstrate a statistically significant ad...
Breaking Medicine Technology:Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 2Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 3Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 4Kiwifruit: Antioxidant Power in Quantity and Quality 2Senesco Chooses VGXI to Produce Factor 5A Plasmid 2Senesco Chooses VGXI to Produce Factor 5A Plasmid 3Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 2Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 3Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 4Freshman class sparks start up company 666 1Freshman class sparks start up company 666 2Differing attitudes found between women and doctors concerning menstrual suppression 2793 1Differing attitudes found between women and doctors concerning menstrual suppression 2793 2First Nationwide Class Action Filed on Behalf of Consumers Who Purchased Topps E Coli Contaminated Ground Beef 2791 1First Nationwide Class Action Filed on Behalf of Consumers Who Purchased Topps E Coli Contaminated Ground Beef 2791 2First Nationwide Class Action Filed on Behalf of Consumers Who Purchased Topps E Coli Contaminated Ground Beef 2791 3Inverness Medical Innovations Acquires Bio Stat Healthcare Group 2787 1Inverness Medical Innovations Acquires Bio Stat Healthcare Group 2787 2
...Apr 19, 2007 - Amgen,(NASDAQ: AMGN) today announce...uble-blind, placebo-controlled, multicenter Phase ...eviously untreated,patients with extensive-stage s...ntaining chemotherapy. The study demonstrated,no s...th (overall,survival Aranesp compared to placebo H...
...Apr 19, 2007 - Aeolus,Pharmaceuticals, Inc. (OTCBB...rchers at Loma Linda University Medical Center,Na... University,showing that one of the Company,s meta...d protection of healthy normal cells in mice,with ...y. The study,also showed that the compound did not...
Other Medicine Technology:Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 2Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 3Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 4Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 5Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 6Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 7Aeolus Pharmaceuticals' AEOL 10113 Demonstrates Potential as a,Protector of Healthy Normal Cells from Cancer Radiation Therapy 2Aeolus Pharmaceuticals' AEOL 10113 Demonstrates Potential as a,Protector of Healthy Normal Cells from Cancer Radiation Therapy 3
Determination of Activated Partial Thromboplastin Time (APTT) by STA Analyzers. Cephalin reagent with particulate (silica) activator.
The ALB method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of albumin in serum
For the quantitative in vitro determination of Total Protein in serum and plasma
The DBIL method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of direct (conjugated) bilirubin in serum and plasma.
Medicine Products: